Home › Triple-Negative Breast Cancer › California › Mountain View
Triple-Negative Breast Cancer clinical trials in Mountain View, CA
8 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- Stanford University, Palo Alto · 5 mi away
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecruitingPhase 3
- El Camino Hospital Cancer Center ( Site 0096), Mountain View
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
RecruitingPhase 2
- Stanford University, Stanford · 5 mi away
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RecruitingPhase 2/3
- Local Institution - 0358, Stanford · 5 mi away
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
RecruitingPhase 1
- Stanford University Medical Center, Palo Alto · 5 mi away
A Study of LY4175408 in Participants With Advanced Cancer
RecruitingPhase 1
- Stanford Medicine Cancer Center, Stanford · 5 mi away
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RecruitingPhase 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi away
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RecruitingPhase 1
- Stanford University, Stanford · 5 mi away
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Mountain View
- Cancer (all types)40 studies
- Breast Cancer26 studies
- Metastatic Cancer25 studies
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Lung Cancer17 studies
- Prostate Cancer15 studies
- Heart Failure15 studies
- Autism13 studies
- Acute Lymphoblastic Leukemia13 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.